New camera could predict skin treatment success
NCT ID NCT05923060
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new video device that takes images of skin lesions during photodynamic therapy (PDT) for actinic keratoses, a common precancerous skin condition. The goal was to see if the device could predict how well the treatment works by measuring certain chemicals in the skin. Fourteen adults with at least 10 lesions on their arms or legs took part. The device was used alongside standard PDT to monitor the treatment in real time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aminolevulinic acid (topical)
What this could lead to
If successful, this imaging technique could help doctors predict which skin lesions will respond best to photodynamic therapy, making treatment more personalized and effective.
What could go wrong
This was a very small, early-phase study with only 14 participants. The device's ability to predict treatment success is still unproven, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, 44195, United States